IRCT20210519051345N13尚未招募未知
In vivo bioequivalence study of Azithromycin 250 mg capsule manufactured by Ani Darman Co. compared with Zithromax®
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- All
入选标准
- •General Health (in terms of Liver, Heart and Kidney)
排除标准
- •History of cardiovascular disease, liver disease and kidney disease,
- •Alcohol and drug addiction,
- •History of drug allergy
研究者
相似试验
尚未招募
不适用
Bioequivalence study of Azithromycin 500 mg tabletIn the present study, no diseases will be examined and products will be administered by healthy volunteers..IRCT20210519051345N4Tabriz University of Medical Sciences24
尚未招募
Unknown
In-vivo Bioequivalence Study of Azithromycin 500 mg Capsules of The Test Drug (ZITHROSAD 500 mg Cap., Sajjad Darou, Iran)IRCT20200105046010N107Sajad darou shargh24
已完成
不适用
Bioequivalence study of Azithromycin 200 mg/5mL powder for oral suspension in healthy Thai volunteer under fasting conditioTCTR20180109003All Research Co., Ltd.42
已完成
不适用
Bioequivalence study of Azithromycin 250 mgIRCT20200623047902N8Sanamed pharma company24
招募中
Unknown
Comparative in vivo evaluation of 2 Azithromycin 250 mg Tablet and Zithromax 250 Tablet formulations.Acute pharyngitisIRCT20180620040164N48Cosar Pharmaceutical Co.24